Nano-X Imaging shares fell $0.695, or 24.39%, in a single day, closing at $2.155 on April 20, 2026. The company had just disclosed a $17.5 million long-lived asset impairment charge and said it would close the chip manufacturing line at its South Korean facility.
A securities class action followed, and the law firm Levi & Korsinsky announced in a July 29 release that investors who bought NNOX securities between March 31, 2025 and April 17, 2026 had until August 11, 2026 to ask the court to make them lead plaintiff. The suit alleges misrepresentations about manufacturing efficiency and product demand during that period.
What a lead plaintiff does
Under the Private Securities Litigation Reform Act of 1995, the court picks one investor, or a small group, to represent the whole class. It typically chooses the applicant with the largest financial interest in the relief sought who is otherwise adequate. The firm says there is no minimum loss threshold.
The lead plaintiff directs the litigation strategy, approves major decisions including any proposed settlement, and selects lead counsel once appointed. Being appointed does not raise an individual’s recovery, the firm’s FAQ says. Applicants do not pay legal fees up front, since counsel is paid only from any recovery for the class.
The statute requires the motion within 60 days of the first public notice of the action. After the deadline the court reviews competing motions, which typically takes several weeks, and the case then moves into discovery and dispositive motions.
Everyone else
Missing the deadline does not shut anyone out. Investors who sit out the lead plaintiff race remain class members and keep the right to share in any settlement or judgment, without appearing in court or testifying.
The firm advises anyone considering an application to gather brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and the dates and prices of any later sales.
“In the Nano-X action, where a single corrective disclosure erased nearly a quarter of the stock’s value, identifying the right lead plaintiff is a critical first step toward accountability,” said Joseph E. Levi of Levi & Korsinsky.





